A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Table 3: Notification rates of diseases, 1 October to 31 December 2010, by state or territory. (Annualised rate per 100,000 population)
Disease |
State or territory | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ACT | NSW | NT | Qld | SA | Tas | Vic | WA | Aust | |
Bloodborne diseases |
|||||||||
| Hepatitis (NEC) | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Hepatitis B (newly acquired)* | 0.0 |
0.3 |
0.0 |
0.7 |
1.2 |
0.0 |
1.2 |
1.1 |
0.7 |
| Hepatitis B (unspecified)† | 25.1 |
35.4 |
65.8 |
21.6 |
22.2 |
10.3 |
34.0 |
47.9 |
32.2 |
| Hepatitis C (newly acquired)*,‡ | 2.3 |
0.3 |
0.0 |
NN |
1.5 |
4.0 |
2.2 |
4.3 |
1.7 |
| Hepatitis C (unspecified)† | 58.1 |
53.3 |
129.9 |
60.4 |
26.4 |
47.0 |
43.8 |
45.2 |
50.2 |
| Hepatitis D | 0.0 |
0.0 |
0.0 |
0.7 |
0.0 |
0.0 |
0.1 |
0.0 |
0.2 |
Gastrointestinal diseases |
|||||||||
| Botulism | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Campylobacteriosis§ | 178.8 |
NN |
76.5 |
113.4 |
169.3 |
150.4 |
166.8 |
132.3 |
144.3 |
| Cryptosporidiosis | 3.4 |
4.3 |
49.8 |
4.4 |
2.7 |
15.1 |
6.1 |
7.0 |
5.6 |
| Haemolytic uraemic syndrome | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
| Hepatitis A | 2.3 |
1.1 |
0.0 |
1.0 |
0.0 |
0.0 |
0.6 |
2.0 |
0.9 |
| Hepatitis E | 0.0 |
0.1 |
0.0 |
0.2 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
| Listeriosis | 1.1 |
0.4 |
0.0 |
0.3 |
0.0 |
1.6 |
0.2 |
0.2 |
0.3 |
| STEC, VTEC|| | 0.0 |
0.1 |
0.0 |
0.4 |
1.5 |
0.0 |
0.3 |
0.5 |
0.3 |
| Salmonellosis | 93.4 |
50.2 |
229.5 |
61.6 |
43.1 |
49.3 |
41.2 |
59.5 |
53.2 |
| Shigellosis | 4.6 |
2.0 |
30.2 |
0.9 |
3.7 |
1.6 |
1.2 |
5.2 |
2.3 |
| Typhoid | 0.0 |
0.3 |
0.0 |
0.2 |
0.5 |
0.0 |
0.4 |
0.2 |
0.3 |
Quarantinable diseases |
|||||||||
| Cholera | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Highly pathogenic avian influenza in humans | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Plague | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rabies | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Severe acute respiratory syndrome | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Smallpox | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Viral haemorrhagic fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Yellow fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Sexually transmissible infections |
|||||||||
| Chlamydial infection§,** | 337.1 |
250.9 |
1,117.2 |
418.5 |
252.9 |
355.7 |
272.0 |
658.8 |
344.4 |
| Donovanosis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Gonococcal infection** | 20.5 |
30.1 |
877.0 |
59.1 |
30.1 |
2.4 |
30.4 |
84.9 |
49.5 |
| Syphilis < 2 years duration** | 2.3 |
4.6 |
19.6 |
3.6 |
0.5 |
1.6 |
4.4 |
6.4 |
4.3 |
| Syphilis > 2 years or unspecified duration** | 5.7 |
1.8 |
39.1 |
2.7 |
- |
0.0 |
10.2 |
3.0 |
4.8 |
| Syphilis – congenital** | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Vaccine preventable diseases |
|||||||||
| Diphtheria | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Haemophilus influenzae type b | 0.0 |
0.0 |
1.8 |
0.2 |
0.0 |
0.0 |
0.2 |
0.4 |
0.1 |
| Influenza (laboratory confirmed) | 19.4 |
28.2 |
407.4 |
125.0 |
267.5 |
21.5 |
25.6 |
116.4 |
77.4 |
| Measles | 0.0 |
0.0 |
0.0 |
0.5 |
0.2 |
0.0 |
0.2 |
0.2 |
0.2 |
| Mumps | 0.0 |
0.5 |
1.8 |
0.7 |
0.0 |
0.0 |
0.2 |
1.4 |
0.5 |
| Pertussis | 549.0 |
278.0 |
174.3 |
255.1 |
655.4 |
74.0 |
211.3 |
111.6 |
266.4 |
| Pneumococcal disease (invasive) | 5.7 |
6.4 |
35.6 |
6.0 |
9.6 |
11.1 |
6.2 |
9.8 |
7.3 |
| Poliomyelitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rubella | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
| Rubella - congenital | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Tetanus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Varicella zoster (chickenpox)†† | 0.0 |
NN |
51.6 |
9.2 |
27.1 |
4.0 |
9.1 |
24.1 |
13.6 |
| Varicella zoster (shingles) †† | 13.7 |
NN |
60.5 |
1.3 |
74.2 |
44.6 |
10.6 |
41.5 |
21.5 |
| Varicella zoster (unspecified) †† | 22.8 |
NN |
0.0 |
92.5 |
19.7 |
13.5 |
40.5 |
44.2 |
52.3 |
Vectorborne diseases |
|||||||||
| Arbovirus infection (NEC) | 0.0 |
0.1 |
12.5 |
0.6 |
0.0 |
0.0 |
0.4 |
0.0 |
0.4 |
| Barmah Forest virus infection | 1.1 |
3.9 |
26.7 |
20.6 |
5.9 |
0.0 |
3.5 |
3.0 |
7.4 |
| Dengue virus infection | 2.3 |
4.1 |
16.0 |
9.0 |
2.7 |
2.4 |
3.5 |
36.8 |
8.2 |
| Japanese encephalitis virus infection | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Kunjin virus infection‡‡ | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Malaria | 0.0 |
1.7 |
3.6 |
4.3 |
0.0 |
2.4 |
0.6 |
3.0 |
2.0 |
| Murray Valley encephalitis virus infection‡‡ | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ross River virus infection | 2.3 |
7.9 |
126.3 |
31.2 |
47.3 |
2.4 |
4.7 |
32.0 |
18.2 |
Zoonoses |
|||||||||
| Anthrax | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Australian bat lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Brucellosis | 0.0 |
0.0 |
0.0 |
0.5 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
| Leptospirosis | 0.0 |
0.1 |
0.0 |
1.8 |
0.2 |
0.8 |
0.4 |
0.4 |
0.6 |
| Lyssavirus (NEC) | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ornithosis | 0.0 |
0.2 |
0.0 |
0.0 |
0.0 |
0.0 |
1.5 |
0.2 |
0.5 |
| Q fever | 0.0 |
1.3 |
1.8 |
3.4 |
0.2 |
0.0 |
0.1 |
0.2 |
1.2 |
| Tularaemia | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Other bacterial infections |
|||||||||
| Legionellosis | 0.0 |
1.1 |
1.8 |
0.6 |
2.7 |
3.2 |
0.7 |
5.0 |
1.5 |
| Leprosy | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.2 |
0.0 |
| Meningococcal infection§§ | 0.0 |
1.1 |
1.8 |
1.0 |
1.5 |
1.6 |
0.8 |
0.9 |
1.0 |
| Tuberculosis | 3.4 |
5.7 |
19.6 |
5.0 |
4.4 |
1.6 |
10.9 |
5.4 |
6.7 |
* Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis.
† Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.
‡ In Queensland, includes incident hepatitis cases.
§ Not reported for New South Wales where it is only notifiable as ‘foodborne disease’ or ‘gastroenteritis in an institution’.
|| Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).
¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia, which reports only genital tract specimens. The Northern Territory and Western Australia, exclude ocular infections.
** In the national case definitions for chlamydial, gonococcal and syphilis infections the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode (e.g. perinatal infections, epidemic gonococcal conjunctivitis).
†† Ratio of current quarter total to the mean of last 5 years for the same quarter. Ratios for varicella zoster (chickenpox), varicella zoster (shingles) and varicella zoster (unspecified) are based on 3 years of data.
‡‡ In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.
§§ Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report conjunctival cases.
NN Not notifiable.
NEC Not elsewhere classified.
NDP No data provided.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 35 No 1, March 2011
Communicable Diseases Intelligence